Summary Murine and human melanoma cells differ relatively reliably from non-tumorigenic melanocytes in certain biological properties. When cultured at low pH, melanocytes tend to be pigmented and melanoma cells unpigmented. The growth of virtually all metastatic melanoma cells is inhibited by phorbol esters such as TPA (12-0-tetradecanoyl phorbol-13-acetate), which stimulate melanocyte growth. Melanocytes fail to grow in suspension culture or produce tumours when implanted in animals, while many melanoma lines can do both. Here we studied which of these properties were dominant in hybrid cells formed by fusion of drug-resistant murine B16-FIORR melanoma cells to melanocytes of the albino and brown lines, melan-c and melan-b. The albino melanocytes are unpigmented but well-differentiated, the brown melanocytes produce pale brown pigment and the melanoma cells are unpigmented under the conditions used. All hybrid colonies observed produced black pigment, except some melan-b/melanoma hybrids when growing sparsely with TPA. Thus pigmentation was generally dominant. 14/15 hybrid lines showed stimulation of proliferation by TPA, as do melanocytes. Most hybrid lines showed no or reduced capacity for growth in suspension, though some grew better in suspension when TPA was present. There was marked suppression of the tumorigenicity of the parental melanoma cells in 4/8 hybrids examined, and tumorigenicity was reduced in the others, despite considerable chromosome loss by the passage level tested. Thus most properties of the non-tumorigenic pigment cells were dominant, as often observed for other cell lineages, and providing further evidence for gene loss in the genesis of malignant melanoma.
The relation between age and incidence suggests that the number of events required to generate malignant melanoma in humans is smaller than that for other cancers (Cook et al., 1969) . The study of melanoma may therefore provide one of the simpler approaches to the formidable problem of analysing what genetic changes, or other somatically heritable events, are required to produce cellular malignancy. These heritable changes can be classed in principle as either dominant -the activation or acquisition of an oncogene that promotes malignancy, or recessive -the loss or repression of a normal cellular gene that suppresses malignancy (Cooper, 1990) . The latter would be called a tumour suppressor gene or anti-oncogene. Changes of both kinds have been identified in human and animal tumours (Cooper, 1990; Harris, 1990; Huang et al., 1988; Nigro et al., 1989) .
To obtain an initial broad picture of whether dominant or recessive changes or both are important in melanoma, we have adopted the classical approach of somatic-cell hybridisation (Harris et al., 1969; Fougere et al., 1972; Wiener et al., 1972; Stanbridge & Ceredig, 1981) . Previous workers have reported the suppression of malignancy in hybrids between melanoma cells and diploid fibroblasts or lymphocytes (Jonasson et al., 1977; Evans et al., 1982) , but we were interested to know whether this suppression would also occur with nontumorigenic cells of the homologous lineage, melanocytes. Another study concluded that the ability of normal cells to reduce malignancy of cancer cells by fusion depended on their somatic origin (Cowell & Franks, 1984) . We were also interested to know the dominance-recessiveness relationships of specific biological properties which are relatively reliable as markers of malignancy in the pigment-cell lineage (Eisinger & Marko, 1982; Albino et al., 1986; Bennett et al., 1987 Bennett et al., , 1989 Dotto et al., 1989; Herlyn et al., 1990) , with a view to further studies of the genes involved. These markers are as follows. Firstly nontumorigenic human or mouse melanocytes are generally well-pigmented (differentiated) in culture whereas malignant melanoma cells are either unpigmented or show light or variable pigmentation. Secondly normal diploid melanocytes will not grow in standard culture medium with serum, and immortal nontumorigenic melanocytes show little or no growth in such media, but both will grow well in the presence of the tumour promoter 12-0-tetradecanoyl phorbol-13-acetate (TPA); however the growth of metastatic melanoma cells in such a medium is inhibited by TPA. Thirdly, as with other cell types from solid tissues, nontumorigenic melanocytes will not grow in suspension in a semisolid medium whereas malignant melanoma lines usually will. Lastly many malignant melanoma lines will form tumours in nude mice or (where applicable) syngeneic animals, whereas nontumorigenic cells by definition will not. It has recently become possible to derive immortal lines of nontumorigenic melanocytes from mice (Sato et al., 1985; Bennett et al., 1987 Bennett et al., , 1989 Tamura et al., 1987) . We have now been able to fuse immortal melanocytes to melanoma cells in culture, and to study the above properties on the resulting hybrid cells. The present results were obtained using murine melanoma cells. The three lines of immortal nontumorigenic melanocytes were the genetically albino (c/c) line melan-c, the brown (b/b) line melan-b (Bennett et al., 1989) , and a doubly drug-resistant subline of the latter, described below. The albino cells are unpigmented but well-differentiated in culture, containing many unpigmented premelanosomes like mature albino melanocytes in vivo (ibid.). The brown melanocytes form pale brown melanin pigment rather than the black produced by wild-type cells. These genetic markers are useful in distinguishing hybrid from parental cells. The melanoma lines were a highly metastatic line from black mice, B16-FIO (Fidler, 1975) , and a doubly drugresistant subline of this, B16-FI0RR (Hart, 1984 Biomedicals (High Wycombe, Bucks., UK). Sources of other materials have been described previously (Bennett et al., 1986 (Bennett et al., , 1989 Diggelmann, 1984) . The transfection medium was as Dulbecco's modification of Eagle's medium (pH 7.4) with TPA and 5% FCS. After a day the cells were washed and returned to melanocyte medium. They were selected in hygromycin B from day 3, generally at 200 IM although the concentration was reduced for very sparse cultures. A small number of resistant colonies were obtained, and some were subcultured after 6 weeks, with cloning rings, to produce cell lines. One clone was selected for further work and designated 'melan-bH .
Trypsinised suspensions of melan-bH cells (1.5 x I07 in all) were mutagenised with 300-600 rad of gamma radiation, replated and cultured until cell death ceased, then exposed to 6-thioguanine (30 Lg ml-') as well as hygromycin B (200 JM Selection regimes were started 24 h after plating. For B16-FlORR/melanocyte fusions, HAT (hypoxanthine, aminopterin and thymidine) (Littlefield, 1964) Subculture of hybrid clones Selected colonies of hybrid cells, assumed to be clones, were subcultured using plastic cloning rings when larger than 400 cells, and replated in 15 mm tissue culture wells with 1 ml of growth medium containing trypsin inhibitor. Hygromycin B and ouabain selections were discontinued at this stage, and HAT was replaced by HT (hypoxanthine and thymidine) only (Littlefield, 1964) for another 7 days. When nearly confluent the hybrid lines were passaged again to 50 mm dishes (passage 2).
Estimation ofpopulation doubling times
Hybrid cell lines at passage 3, or parental lines at passage levels near those used for fusion, were plated on four 90 mm dishes at 2 x 104 ml-', 10 ml/dish. TPA (200 nM) was added to two dishes. Cells were harvested after incubation for 96 h, and pooled from both dishes. The cell number was estimated by quadruplicate haemocytometer counts; an arithmetic mean was taken, and crude doubling times were calculated from this and the plating density.
Clonal growth in suspension This assay was a modification of the two-phase agar system (e.g. Freedman & Shin, 1974) . The culture medium was Ham's FIO with 18 mM bicarbonate (pH 6.9), 5% FCS and 100 tLM 2-ME, throughout. Four ml of medium containing 0.6% Seaplaque agarose were allowed to set in each 50 mm tissue culture dish. This was overlaid with 2 ml of medium containing 0.3% agarose and 200 hybrid cells at passage 3, or parental cells. Triplicate cultures were incubated for each treatment. Two ml of medium were added on day 7 and renewed on day 14. TPA (200 nM) was included in the agarose mixtures and liquid medium where specified. After 21 days, colonies were counted and their diameters were determined, with an inverted microscope (Olympus) equipped with a calibrated eyepiece graticule.
Tumorigenicity tests
Cell lines were implanted into BALB/c thymus-deficient (nul nu) mice and C57BL/6 mice (syngeneic with B16 cells). Each of four or five mice per line received 106 hybrid cells or 5 x 104 melanoma cells in 0.2 ml PBSA, subcutaneously in the flank region, and was assessed for palpable tumour growth twice weekly for 11 or 12 weeks, except that mice with tumours larger than 1 cm were killed for autopsy.
Karyotypic analysis Hybrid cells at passage 3, melan-c and melan-b at higher passage levels than used for fusion, and the B16-FI0RR line were examined for marker chromosomes by standard trypsinGiemsa banding, essentially as described elsewhere (Muschel et al., 1986) . The means and ranges of chromosome numbers were estimated from approximately 20 spreads per line.
Results

Pigmentation
None of the parental lines used here have black pigment under the culture conditions described, for genetic reasons in the case of the albino and brown melanocytes (see Introduction). B16-FIO melanoma cells are from C57BL black mice, but when kept below confluence and at low pH as described (Materials and methods) they are unpigmented (Bennett et al., 1986) , as are B16-F10RR cells. However black pigment was observed in hybrid cells in all the following cases. Hybrid cells or colonies were taken to be those surviving after all cells in separate cultures of the parental lines had been killed by the drug selections. Counts were performed when discrete, sizeable colonies were visible: day 14 or 21 as specified.
After fusion of melan-c albino melanocytes to B16-Fl0RR cells, small pigmented colonies and single cells were first observed after 7 days (in dishes containing TPA). One hundred per cent of hybrid cells and colonies at day 14 had black pigment (Figure 1 (Figure 3a ), but those obtained in the presence of TPA included many unpigmented colonies as well as pigmented ones (Figure 2c ). However at a later stage, such unpigmented colonies frequently showed pigmentation at the colony centre, which became more extensive over 2-3 days as the colonies enlarged. Thus the proportion of completely unpigmented colonies at 14 days (68% of the total in Figure 2c ) was probably an arbitrary figure reflecting the colony size distribution. After subculture of unpigmented hybrid clones, onset of pigmentation was observed as they neared confluence, indicating that the pigmentation appeared at higher local cell densities (as found in (Laskin et al., 1980) . When the TPA supplement was omitted from subcultures of unpigmented melan-b/B16-FlO1RR hybrid colonies, plated at low cell density (2 x 104mlh'), local pigmentation was observed within 5 days ( Figure 3b ) and all cells pigmented over a longer period.
General observations on hybrid clones subcultured as cell lines Selected colonies were subcultured from day 21 onwards (Methods), for further characterisation. They were selected initially for differences in colony size, pigmentation and morphology, and from cultures originally grown with and without TPA. Cell morphology of most hybrids proved however to vary with cell density and perhaps passage number, and could not therefore be used reliably to classify hybrid cell lines. Pigmentation also varied with cell density in melan-b/ B16-FlORR hybrids as just described.
It should be stressed that the 19 hybrid lines studied cannot necessarily be taken as a completely representative sample of the thousands of original hybrids, especially given that many of the latter failed to grow progressively at all (Figure 2) . Proliferation rates of hybrid lines and effects of TPA Lines from hybrid colonies selected initially in the presence or the absence of TPA were each passaged into media both with and without TPA. Estimates of crude doubling times over 4 days showed that all hybrids grew more slowly than the melanoma cells under both conditions, while most melanoma/melanocyte hybrids grew faster than the parental melanocyte lines (Table I ). All tested hybrid clones showed a stimulation of growth by TPA, except one; this one (F7.1 1B) was a melan-b/B16-FIO hybrid initially obtained without TPA (Table I) .
The melanocyte/melanocyte hybrids had doubling times comparable with those of the parental lines in the presence of TPA. When TPA was excluded from the culture medium their rate of proliferation slowed markedly over 4 days (Table I) , and they adopted a more epithelioid morphology, also characteristic of melanocyte lines (Bennett et al., 1987 (Bennett et al., , 1989 . The effects of TPA on the Bl 6-FlORR parental line were also examined, as this had not been done previously. Pro (Bennett et al., 1989) . cHybrid lines designated A and B were selected originally in the presence and absence of TPA, respectively. dNo significant change in cell number. work with B16-F10 cells (non-drug-resistant) showed that after two subcultures (7 days) in the presence of TPA, their growth rate with TPA over the next 4 days was markedly lower, typical doubling times being 1.0-1.1 days, compared with 0.65-0.7 days without TPA for this line (increases of around 15-fold instead of 60-fold over 4 days).
Clonogenicity of hybrid lines in semisolid agarose, and effects of TPA The percentages of cells forming colonies in suspension in two-phase agarose, for parental and hybrid lines, are shown in Table IT . The two melanocyte lines and all hybrids between them formed no colonies in suspension, with or without TPA, while the clonogenicity of the parental melanoma cells was high (52%) in the absence of TPA, or lower (6%) in its presence. The melanocyte/melanoma hybrid lines varied in their capacity to grow in suspension. Among melanb/B16 hybrids, most (4/7) formed no colonies, two had cloning efficiencies below 1% with or without TPA and the remaining line had clonogenicities of 0 in the absence of TPA and 1.5% in its presence. Thus the ability of melan-b/B16 hybrids to grow in suspension was zero or markedly lower than that of the melanoma cells; where not zero it may have been stimulated slightly by TPA. Of eight melan-c/B16 hyb- (96) (97) (98) (99) (100) (101) (102) (103) (104) (105) (106) .
These numbers and the presence and numbers of B16-F1ORR marker chromosomes in each hybrid suggested that all the hybrids examined had originally received a single nucleus from each parental line. Chromosome loss was thus quite extensive in all hybrids, even at the earliest possible stage for study after fusion (passage 3).
Discussion
Pigmentation
The pigmentation of the melanocyte/melanoma hybrid clones was most interesting. It appeared that all melan-c/B16 hybrid cells were black-pigmented, so that the differentiated state of the normal melanocytes was unequivocally dominant here. The same can be said of melan-b/B16 hybrid cells cultured without TPA. However the latter hybrids in the presence of TPA behaved somewhat like B16 melanoma cells grown without TPA: pigmentation was absent in sparse cultures but appeared in locally dense areas. We have no explanation for this difference between the two sets of hybrids. It presumably reflects a difference between the melan-b and melan-c lines, which probably arose during their establishment rather than Table III Tumorigenicity .5B (L) 0/4 1/4 2/4 0/4 1/4 4/4 + aNumber of mice with tumours out of total surviving mice, assessed as described in Materials and methods using 106 hybrid cells per mouse, or 5 x 104 B16-FIORR melanoma cells. ND: not done; hybrid lines were tested in both C57BL/6 and nu/nu mice in case they were rejected by the C57BL/6 mice, whereas B16-FlORR cells were tested only in C57BL/6 mice with which they are syngeneic. bSummary of tumorigenicity: (-) : no tumours in 12 weeks; (+): low tumorigenicity -under 30% mice with tumours in 6 weeks; (+ +): tumorigenic but < 100% in 4 weeks; (+ + +):
highly tumorigenic -100% in 4 weeks (or in 2 weeks; see text), from a much smaller inoculum. C(L) and (H) designate low and high clonogenicities in suspension, respectively (see Table II ).
from the mouse strains of origin. The melan-c/melanoma hybrids did appear less pigmented when growing with TPA than without, but did not become unpigmented. Possibly melan-b cells are in some sense less maturely differentiated than melan-c cells, producing a corresponding difference in their hybrids with B16-FIO cells. Human melanoma cells have been classified into three sets with different levels of differentiation (Houghton et al., 1987) ; however both melanb and melan-c cells would fall into the most-differentiated class in this system, since they synthesise melanosomes and melanosomal enzymes.
These results are comparable with other reports that when non-tumorigenic cells with a differentiated function, such as keratinocytes, are fused to malignant cells of another lineage, the hybrids before extensive chromosome loss tend to adopt the program of differentiation of the non-tumorigenic fusion partner, this behaviour usually being associated with a lack of tumorigenicity (Wiener et al., 1972; Stanbridge & Ceredig, 1981; Cowell & Franks, 1984; Harris, 1990) , although not always (Cowell & Franks, 1984 ). An early report of two hybrid lines, formed by spontaneous fusion in vivo between subtetraploid mouse melanoma cells and unknown diploid host cell types(s), mentioned that both lines, while tumorigenic, showed increased pigment synthesis in culture compared to the melanoma cells (Halaban et al., 1980) . An incidental outcome of the pigmentation of our hybrid cells was that we could identify them at a very early stage, as groups of one or a few black cells. This permitted the additional observation that many hybrids, in fact the majority of melan-c/B16 hybrids (Figure 2) 
Growth in suspension
The high clonogenicity in agarose of the B16-FI0RR melanoma cells was suppressed completely in some hybrids with melan-b, and in some hybrids with melan-c so long as TPA was absent. Other hybrids grew in suspension to various extents, though none grew in the absence of TPA so well as the melanoma cells. The growth rates of different hybrid lines on a substrate with and without TPA did not correlate well with their growth in agarose, so the stimulation of hybrid cell growth in suspension by TPA cannot be attributed in a straightforward way to its ability to stimulate cell proliferation. In general the variability in growth in agarose within and between the lines may be attributable to variable loss of relevant chromosome(s). However suppression of melanoma growth in agarose appeared more marked in hybrids with melan-b than with melan-c cells, even though rates of chromosome loss by passage 3 appeared to have been similar in both sets in those hybrids karyotyped. This suggests instead another pre-existing difference between the two melanocyte lines.
Tumorigenicity
There is a consensus from previous studies that hybrids between non-tumorigenic and tumorigenic cells (including melanoma cells) tend to be non-tumorigenic before chromosome loss (e.g. Stanbridge & Ceredig, 1981; Harris, 1990) . Our results are consistent with this idea; the observation of some mice free of tumours at the end of the assay period, and the often long latent periods, indicate that in general the tumours arose from a small minority of the implanted cells. Tumorigenicity would be below 1 cell in 106 for lines not tumorigenic in all mice. This represents almost complete suppression as compared to B16-Fl0RR cells, of which at least 1 in 50,000 is tumorigenic from Table III , and at least 1 in 500 in the tests of Hart (1984) (under different conditions). Considerable chromosome loss had occurred by the passage (number 5) at which enough cells were available for implantation in mice, so that the tumours observed can be explained by the loss of chromosome(s) necessary for suppression. The observation that no tested hybrid was as tumorigenic as the melanoma cells suggest that more than one gene from the melanocytes was capable of reduction of tumour growth.
Incidentally a suppression of tumorigenicity is not caused by hybridisation itself in these cells. Hart (1984) fused B16-F1ORR cells to various other cell lines and observed a reduction of malignancy only when the other line was non-tumorigenic. Similar results were obtained by others; for example 16/16 hybrid lines from combinations of various other tumorigenic murine lines were tumorigenic (Wiener et al., 1973) , and human tumour lines too remained tumorigenic when crosshybridised (Stanbridge et al., 1982) .
None of the other cellular properties analysed (pigmentation at low pH, response to TPA and growth in agarose) was a predictor of the tumorigenicity of these hybrid clones, but this finding is compromised by the cellular heterogeneity resulting from variable chromosome loss. The properties measured in vitro are those of the majority cell population, but the tumorigenicity depends on the most tumorigenic cells present, often a small subpopulation as just mentioned, of which the properties in vitro would not be known -e.g. growth in suspension of 1 in 106 cells would not be detected. Moreover, tumorigenicity tests were done two passages later than the other tests, allowing further chromosome loss. Each of the said properties is correlated with cellular malignancy among pigment cell lines in general (see Introduction).
Implications for melanoma genetics In short, of the properties studied in these hybrid cells, most seemed closer to those of the non-tumorigenic melanocytes than those of the melanoma cells, and chromosome loss was sufficient to account for most deviations from this rule, even though the melanocytes used here were immortal rather than fully normal. It is possible that a still higher degree of 'normalisation' would have been seen with newly explanted, diploid murine melanocytes, which, however, are difficult to work with because of their rapid senescence and overgrowth by immortal cells.
In a detailed cytogenetic study of hybrids between a murine melanoma and diploid fibroblasts or lymphocytes, it was concluded that tumour suppression was seen only when a hybrid retained one or both copies of the normal mouse chromosome 4 (Jonasson et al., 1977) . Copies of normal chromosome 4 were also implicated in suppression of malignancy of other types of tumour, and evidence was presented that the ratio between numbers of normal and tumourderived chromosomes 4 was important in whether suppression was observed (Evans et al., 1982) . The capacity for suppression was localised to a specific region of this chromosome (Jonasson et al., 1977) , restated to be bands A4-C3 (Harris, 1990) . This contains a region of homology to human chromosome 1, arm lp, chromosome 1 being associated with suppression of malignancy of a hamster cell line (Stoler & Bouck, 1985; Harris, 1990) . There is also a small region syntenic with human chromosome 6q (Ceci et al., 1989) . Human chromosome 6 has been directly shown, by microcellmediated chromosome transfer, to suppress malignancy of two human melanoma lines in nude mice (Trent et al., 1990) . Human chromosome arms lp and 6q are those most commonly subject to deletions and translocations in melanomas (Trent et al., 1989) . One group has mapped a familial susceptibility to cutaneous melanoma to human chromosome lp36 (Bale et al., 1989) , although other groups have reported conflicting data. All these findings suggest the loss of specific normal genes in melanoma.
Here the genetic analysis was extended to cellular properties observed in vitro. It is concluded that, here too, properties of the normal pigment cells tend to be dominant over those of melanoma cells, the most reliable being pigmentation and a positive growth response to TPA. These findings are of considerable practical value, providing two relatively rapid assays for the normal cellular gene or genes responsible. These assays will permit attempts at chromosome-mediated or DNA-mediated transfer of these biological properties from normal cells to melanoma cells. Any sequence capable of conferring one or both properties would be most interesting, not only as a candidate melanoma suppressor gene.
